Dolphin C T, Caldwell J, Smith R L
Department of Pharmacology, St. Mary's Hospital Medical School, London, U.K.
Biochem Pharmacol. 1987 Nov 15;36(22):3835-40. doi: 10.1016/0006-2952(87)90446-1.
The effect of the immunomodulator, poly rI:rC, upon the in vivo metabolism of [14C]-paracetamol has been investigated in male BALB/cJ mice. In both poly rI:rC treated and control groups of mice the major part of the dose was excreted in the 0-24 hr urine and the major urinary metabolites were the glucuronic acid and sulphate conjugates. The urinary excretion of these two conjugates and of free paracetamol was not significantly altered following poly rI:rC treatment. Following enzymic hydrolysis of glucuronides and sulphates, the 3-cysteine, 3-mercapturate, 3-thiomethyl and 3-methylsulphoxide metabolites of paracetamol were all identified in the 0-24 hr urine together with very small amounts of 3-methoxy paracetamol. Although poly rI:rC treatment reduced the proportional urinary excretion of each of the thio adducts the individual differences were not significant. However, total thio adduct excretion, an indirect estimate of the metabolic activation of paracetamol, was significantly lower following poly rI:rC treatment. This depression in the urinary excretion of thio adducts following poly rI:rC treatment is discussed in relation to possible implications for paracetamol toxicity.
已在雄性BALB/cJ小鼠中研究了免疫调节剂聚肌苷酸:聚胞苷酸(poly rI:rC)对[14C] - 对乙酰氨基酚体内代谢的影响。在聚肌苷酸:聚胞苷酸处理组和对照组小鼠中,大部分剂量在0 - 24小时尿液中排出,主要尿代谢物为葡萄糖醛酸和硫酸盐结合物。聚肌苷酸:聚胞苷酸处理后,这两种结合物以及游离对乙酰氨基酚的尿排泄量没有显著改变。在对葡萄糖醛酸苷和硫酸盐进行酶水解后,在0 - 24小时尿液中鉴定出对乙酰氨基酚的3 - 半胱氨酸、3 - 巯基尿酸、3 - 硫代甲基和3 - 甲基亚砜代谢物以及极少量的3 - 甲氧基对乙酰氨基酚。虽然聚肌苷酸:聚胞苷酸处理降低了每种硫代加合物的尿排泄比例,但个体差异不显著。然而,聚肌苷酸:聚胞苷酸处理后,硫代加合物的总排泄量(对乙酰氨基酚代谢活化的间接估计)显著降低。讨论了聚肌苷酸:聚胞苷酸处理后硫代加合物尿排泄量的降低对乙酰氨基酚毒性可能产生的影响。